Rafaella’s Literature Update

Be-cause Health & QUAMED literature updates ·         Ref. Bourasseau, A., Lavergne, L. & Ravinetto, R. Assessments of the quality systems of pharmaceutical distributors: a remote approach to be applied in times of COVID-19 and beyond. J of Pharm Policy and Pract 2021; 14, 43 Dear Friend, Today, I would like to present a very recent publication, which just appeared in ...

RAFAELLA’S LITERATURE UPDATE

Be-cause Health & QUAMED literature updates Ref. Tuck C et al.  Quality assurance and cancer medicines in low-income and middle-income countries. Lancet Oncol 2021; 22: 301-3. Available at https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(21)00055-3/fulltext?rss=yes Dear Friend, I would like to highlight a short but important commentary from Tuck and colleagues, raising awareness on the quality challenges for cancer medicines available in ...

Raffaella’s literature update

Be-cause Health & QUAMED literature updates Ref Hauk C, SchafermannS, Martus P, Muzafarova N, Babaley M, Waning B, et al. (2020) Quality assurance in anti-tuberculosis drug procurement by the Stop TB Partnership—Global Drug Facility: Procedures, costs, time requirements, and comparison of assay and dissolution results by manufacturers and by external analysis. PLoS ONE 15(12): e0243428.  ...

Raffaella’s literature update

Be-cause Health & QUAMED literature updates Ref. Ndomondo-SigondaM, Mahlangu G, Agama-Anyetei M, Cooke E (2020) A new approach to an old problem: Overviewof the East African Community’s MedicinesRegulatory Harmonization initiative. PLoS Med 17(8):e1003099. https://doi. org/10.1371/journal.pmed.1003099   Dear Friend,  The capacity to regulate medical products is key for ensuring the quality, safety, and efficacy of medical products ...